# INCRUSE ELLIPTA
> **NDA205382** · New Drug Application · Sponsor: GLAXO GRP ENGLAND · Approved 2014-04-30
## Drug
- **FDA Application Number:** NDA205382
- **Application type:** New Drug Application
- **Brand name:** INCRUSE ELLIPTA
- **Generic name:** UMECLIDINIUM
- **Active ingredients:** UMECLIDINIUM BROMIDE
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** GLAXO GRP ENGLAND
- **Manufacturer:** Prasco Laboratories
- **First approval:** 2014-04-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205382)
---
*AI Analytics · CC0 1.0*